Cabaletta Bio, Inc.
CABA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001759138
No open-market purchases or sales by Cabaletta Bio, Inc. insiders were filed in the last 90 days; 139 institutions reported holding it in 13F filings for Q2 2026, worth $490.4M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Cabaletta Bio, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 109 | 2 | 93 | −14 |
| Shares | 38.4M | 434.8K | 36.3M | −1.69M (−4.5%) |
| Value | $87.2M | $987.0K | $50.3M | −$35.9M (−41.6%) |
2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Cabaletta Bio, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Schonfeld Strategic Advisors LLC | 1,662,401 | $2.30M | 0.02% |
| Nuveen, LLC | 434,389 | $601.6K | 0.00% |
| Almitas Capital LLC | 367,491 | $509.0K | 0.17% |
| AQR Capital Management LLC | 73,956 | $102.4K | 0.00% |
| Callan Family Office, LLC | 41,599 | $57.6K | 0.00% |
| Oxford Asset Management LLP | 15,405 | $21.3K | 0.01% |
| CRA Financial Services, LLC | 11,000 | $15.2K | 0.00% |
| Neuberger Berman Group LLC | 10,565 | $14.6K | 0.00% |
| Caitong International Asset Management Co., Ltd | 1,409 | $1.95K | 0.00% |
| Citadel Advisors LLC | 350 | $485 | 0.00% |
| Coldstream Capital Management Inc | 280 | $388 | 0.00% |
| Boston Private Wealth LLC | 231 | $320 | 0.00% |
| CoreCap Advisors, LLC | 151 | $209 | 0.00% |
| EverSource Wealth Advisors, LLC | 90 | $125 | 0.00% |
| Rothschild Investment LLC | 70 | $97 | 0.00% |
| True Wealth Design, LLC | 63 | $88 | 0.00% |
Sold out (30)
Institutions that held Cabaletta Bio, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
Not filed for Q1 2025 yet (2)
Institutions that held Cabaletta Bio, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 434,389 | $986.1K |
| WR Wealth Planners, LLC | 417 | $947 |